The 10th Anniversary of Medicines: Future Directions
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1934
Special Issue Editor
Interests: informatics; information network; pharmacy; biological pharmacy; basic medicine; general pharmacology; boundary medicine; laboratory medicine; dentistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Medicines (ISSN 2305-6320) is an international, peer-reviewed, and open access journal aiming to create a platform covering all areas of medical disciplines and subspecialties. It publishes original research papers, case reports, and systematic reviews on all aspects of basic, clinical, and translational research in relation to human health. The journal will accept manuscripts on medical concepts that include evidence-based medicine (e.g., Western medicine) and/or alternative medicine (e.g., Oriental medicine such as Traditional Chinese medicine and Kampo medicine). The inaugural Special Issue of Medicines (63 pages) was released in December 2014, by the founding Editor-in-Chief Prof. Dr. Gerhard Litscher from Medical University of Graz (Austria). With the rapid advancement of science and technology, the editorial board has grown, with a second Editor-in-Chief (Prof. Dr. Hiroshi Sakagami from Meikai Research Institute of Odontology), two Section Editor-in-Chiefs, two Associate Editors, one Section Associate Editor, 45 Editorial Board Members and 4 Section Board Members joining since March 2020. Among the 613 articles published so far, 190 articles have been cited 10 times or more, giving it an H5-Index of 35 (Alternative and Traditional Medicine). In order to improve the quality of papers, Medicines has invited highly potential young researchers to be section board members. Due to the rigorous revision processes, the quality of submitted papers has considerably improved. This led to the significant increase in the number of views of full-text and abstract over the past five years (2017~2021): 3.6-fold (120,711 to 431.659) and 5.8-fold (85,321 to 492,742), respectively.
In December 2023, Medicines will celebrate its 10th anniversary, and so we are planning to publish the Special Issue "The 10th Anniversary of Medicines: Future Directions". We hope that the Editorial Board Member of each of the sections of Medicines will consider submitting their articles on systematic reviews, current and future research, including the development of new products and services that ultimately improve quality of life. This invitation is extended to all active researchers, clinical doctors and practitioners with research interest in the field of medicines.
Prof. Dr. Hiroshi Sakagami
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- allergic diseases
- cancer biology and anticancer therapeutics
- cardiology and vascular diseases
- emergency medicine and critical care
- endocrinology and metabolic disorders
- epidemiologic diseases
- gastroenterological and hepatopancretobiliar disorders
- immunologic diseases
- infectious diseases
- nephrology and urology
- neurology and neurologic diseases
- new drugs exploration and development
- oral medicine and dentistry
- pneumological diseases
- psychiatric diseases
- rare diseases
- stem cell investigation and regenerative medicine